Last updated:
ID:
44972
Start date:
4 March 2020
Project status:
Closed
Principal investigator:
Professor Folkert Asselbergs
Lead institution:
University Medical Center Utrecht, Netherlands

Precision medicine is a form of healthcare where disease prevention and treatment is tailored to the individual patient. Besides environmental factors and lifestyle, also genetic variation is taken into account. This proposal will aim to simulate potential effects of pharmacological and lifestyle interventions in an individual person. Much of the knowledge we possess about genomic risk factors comes from statistical measures of association from large-scale population studies. The conceptual and practical disconnect between the populations we study and the individuals we want to treat is a major topic in research. The primary goal of this proposal is to develop a methodology based on machine learning to facilitate precision medicine for CVD patients by connecting population and individual genomic phenomena. We aim to develop a so-called data mining-based workbench, which will allow clinicians to carry out thought experiments about the treatment of individual patients using models of CVD risk derived from population-level studies. This will help clinicians understand how these risk factors might be useful for the diagnosis and treatment of an individual, accelerating the translation of genomic findings into the clinic.
The proposed APM-GDM is based on representation learning which means it can be fed with raw data and automatically extract necessary representation for predictions. An ensemble method or a DL network can provide representations at different levels. In neural networks, for example, the output of each of hidden layers is considered as the representation at that level. The higher layers the data belong, the more abstract representations we get for these data. In different studies, these higher-level representations of raw data prove to be very effective for classification or detection problems.
The project will be conducted for three years and intend to use as many individuals as available to satisfy the need for statistical and machine learning.

Related publications

Author(s)
Arjen J. Cupido, Folkert W. Asselbergs, A. Floriaan Schmidt, G. Kees Hovingh
Journal
Journal of the American Heart Association
  • heart and blood vessels
  • nutrition and metabolism
Author(s)
Jasmine Gratton, Marta Futema, Steve E. Humphries, Aroon D. Hingorani, Chris Finan, Amand F. Schmidt
Journal
JACC Advances
Author(s)
Arjen J. Cupido, Laurens F. Reeskamp, Aroon D. Hingorani, Chris Finan, Folkert W. Asselbergs, G. Kees Hovingh, Amand F. Schmidt
Journal
JAMA Cardiology
  • eye
  • heart and blood vessels
  • nutrition and metabolism
Author(s)
A. F. Schmidt, C. Finan, J. van Setten, E. Puyol-Antón, B. Ruijsink, M. Bourfiss, A. I. Alasiri, B. K. Velthuis, F. W. Asselbergs, A.…
Journal
Communications Medicine
Author(s)
Katarzyna Dziopa, Nishi Chaturvedi, Folkert W. Asselbergs, Amand F. Schmidt
Journal
Communications Medicine
Author(s)
Tycho R Tromp, Arjen J Cupido, Laurens F Reeskamp, Erik S G Stroes, G Kees Hovingh, Joep C Defesche, Amand F Schmidt, Linda Zuurbier
Journal
Atherosclerosis
  • genetic diseases
  • nutrition and metabolism

All publications